Sustained lowering of systolic blood pressure using an endothelial cell-targeted adenoviral vector

Sustained lowering of systolic blood pressure using an endothelial cell-targeted adenoviral vector

Bibliographic Details
Main Authors:	Miller, W, Brosnan, M, Graham, D, Channon, K, Reynolds, P, Baker, A, Dominiczak, A
Format:	Conference item
Published:	2004

Similar Items

Endothelial targeting of adenoviral vectors expressing eNOS lowers blood pressure in a rat model of genetic hypertension
by: Miller, W, et al.
Published: (2004)

Adenoviral-mediated systemic administration of candidate therapeutic genes in a model of genetic hypertension
by: Miller, W, et al.
Published: (2003)

Targeted delivery of adenovirus expressing eNOS to the endothelium in vivo lowers blood pressure in hypertensive rats
by: Miller, W, et al.
Published: (2004)

Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats.
by: Miller, W, et al.
Published: (2005)

Systemic gene transfer of oxidant stress genes and blood pressure in a model of genetic hypertension
by: Miller, W, et al.
Published: (2003)

Adenoviral vectors for gene therapy /
by: Curiel, David T., et al.
Published: (2002)

Construction and application of adenoviral vectors
by: Hongbo Zhang, et al.
Published: (2023-12-01)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
by: Qiwei Zhang, et al.
Published: (2022-03-01)

Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats.
by: Brosnan, M, et al.
Published: (2002)

Unravelling the Distinct Effects of Systolic and Diastolic Blood Pressure Using Mendelian Randomisation
by: Nhu Ngoc Le, et al.
Published: (2022-07-01)

Adenoviral vectors as novel vaccines for influenza.
by: Coughlan, L, et al.
Published: (2015)

Engineering Adenoviral Vectors with Improved GBM Selectivity
by: Emily A. Bates, et al.
Published: (2023-04-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
by: Ewer (nee Russell), K, et al.
Published: (2017)

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
by: Jingao Guo, et al.
Published: (2018-07-01)

Deep Breathing Relaxation Techniques to Lowering Systolic Blood Pressure in the Elderly: Randomized Control Trial
by: Novian Mahayu Adiutama, et al.
Published: (2022-04-01)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
by: Iampietro, M, et al.
Published: (2018)

Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
by: Jian Gao, et al.
Published: (2020-05-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
by: Katie Ewer, et al.
Published: (2017-12-01)

The normal distribution application: systolic blood pressure
by: Svistova Svetlana, et al.
Published: (2023-01-01)

High Systolic Blood Pressure: focus on arterial elasticity
by: Zh. D. Kobalava, et al.
Published: (2006-12-01)

Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.
by: Qian, H, et al.
Published: (2001)

Optimal systolic and diastolic blood pressure threshold that associated with lower risk of white matter hyperintensity progression
by: Sibo Liu, et al.
Published: (2023-10-01)

Systolic blood pressure as a predictor of pathologic mobility of kidney
by: V. L. Medvedev, et al.
Published: (2014-10-01)

Quantitative analysis of adenoviral vector modification of a cytokine-mediated cell death decision
by: Miller, Kathryn Elizabeth
Published: (2008)

Neuropathological consequences of delivering an adenoviral vector in the rat brain.
by: McMenamin, M, et al.
Published: (2004)

Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
by: Luca Scarsella, et al.
Published: (2024-02-01)

Pandemic-response adenoviral vector and RNA vaccine manufacturing
by: Zoltán Kis, et al.
Published: (2022-03-01)

Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
by: Tasneem Farhad, et al.
Published: (2022-10-01)

Cardiac MR modelling of systolic and diastolic blood pressure
by: Samer Alabed, et al.
Published: (2023-11-01)

A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth Factor cDNA In Vitro
by: Ilnur I. Salafutdinov, et al.
Published: (2023-07-01)

Immune responses to adenoviral vectors during gene transfer in the brain.
by: Kajiwara, K, et al.
Published: (1997)

Simulating the impact of targeting lower systolic blood pressure and LDL-cholesterol levels on type 2 diabetes complication rates
by: Mostafa, S, et al.
Published: (2018)

Systolic blood pressure levels and mortality in Australian medical inpatients
by: Jin Nuo Joan Tsang, et al.
Published: (2023-11-01)

Blood pressure-lowering treatment lowers mortality and cardiovascular disease risk, but whether effects differ at an arbitrary threshold of 140 mm Hg systolic blood pressure requires further research
by: Canoy, D, et al.
Published: (2018)

SAVector: Vectored Systolic Arrays
by: Sangun Choi, et al.
Published: (2024-01-01)

The recent English trend in systolic blood pressure and its relationship with age.
by: Kumar, R, et al.
Published: (2013)

The recent English trend in systolic blood pressure and its relationship with age
by: Kumar, R, et al.
Published: (2013)

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
by: Kelly, C, et al.
Published: (2011)

Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors
by: Florian Kreppel, et al.
Published: (2021-02-01)

High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
by: Ana Ricobaraza, et al.
Published: (2020-05-01)